Phreesia, Inc. (NYSE:PHR) COO Evan Roberts Sells 16,005 Shares

Phreesia, Inc. (NYSE:PHR) COO Evan Roberts sold 16,005 shares of the stock in a transaction that occurred on Thursday, February 13th. The stock was sold at an average price of $30.00, for a total transaction of $480,150.00. Following the completion of the sale, the chief operating officer now directly owns 748,302 shares of the company’s stock, valued at $22,449,060. This represents a 2.09 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link.

Evan Roberts also recently made the following trade(s):

• On Monday, January 27th, Evan Roberts sold 10,716 shares of Phreesia stock. The stock was sold at an average price of $27.48, for a total transaction of $294,475.68.
• On Tuesday, January 21st, Evan Roberts sold 12,749 shares of Phreesia stock. The stock was sold at an average price of $27.31, for a total transaction of $348,175.19.
• On Wednesday, January 15th, Evan Roberts sold 1,785 shares of Phreesia stock. The shares were sold at an average price of $26.98, for a total transaction of $48,159.30.
• On Wednesday, January 8th, Evan Roberts sold 2,681 shares of Phreesia stock. The shares were sold at an average price of $27.95, for a total value of $74,933.95.
• On Monday, January 6th, Evan Roberts sold 2,873 shares of Phreesia stock. The shares were sold at an average price of $26.61, for a total value of $76,450.53.

Phreesia Trading Up 0.5 %

Shares of NYSE:PHR traded up $0.15 on Tuesday, hitting $29.99. 409,526 shares of the company’s stock were exchanged, compared to its average volume of 382,504. Phreesia, Inc. has a 12 month low of $17.07 and a 12 month high of $30.53. The stock has a market capitalization of $1.74 billion, a price-to-earnings ratio of -20.40 and a beta of 0.96. The business’s 50 day simple moving average is $26.93 and its two-hundred day simple moving average is $23.68. The company has a debt-to-equity ratio of 0.04, a current ratio of 1.74 and a quick ratio of 1.74.

Phreesia (NYSE:PHR) last released its earnings results on Monday, December 9th. The company reported ($0.25) earnings per share for the quarter, topping the consensus estimate of ($0.29) by $0.04. Phreesia had a negative return on equity of 32.78% and a negative net margin of 20.43%. The business had revenue of $106.80 million during the quarter, compared to the consensus estimate of $106.33 million. During the same period last year, the company earned ($0.58) earnings per share. The business’s revenue for the quarter was up 16.6% compared to the same quarter last year. Analysts anticipate that Phreesia, Inc. will post -1.1 EPS for the current fiscal year.

Wall Street Analyst Weigh In

PHR has been the subject of a number of research reports. Robert W. Baird lowered their target price on Phreesia from $34.00 to $30.00 and set an “outperform” rating for the company in a research report on Wednesday, December 11th. Citigroup increased their target price on Phreesia from $31.00 to $35.00 and gave the company a “buy” rating in a research report on Friday, January 10th. Piper Sandler reiterated an “overweight” rating and set a $33.00 target price (up from $31.00) on shares of Phreesia in a research report on Wednesday, January 29th. KeyCorp raised their price target on Phreesia from $28.00 to $30.00 and gave the stock an “overweight” rating in a research report on Wednesday, January 8th. Finally, Royal Bank of Canada upgraded Phreesia from a “sector perform” rating to an “outperform” rating and raised their price target for the stock from $24.00 to $32.00 in a research report on Wednesday, January 8th. Thirteen investment analysts have rated the stock with a buy rating, According to MarketBeat, the stock has a consensus rating of “Buy” and a consensus price target of $31.15.

Institutional Trading of Phreesia

Several institutional investors and hedge funds have recently made changes to their positions in the business. Versor Investments LP purchased a new position in shares of Phreesia during the third quarter valued at $694,000. Zacks Investment Management purchased a new position in shares of Phreesia during the third quarter valued at $631,000. State Street Corp increased its stake in shares of Phreesia by 7.1% during the third quarter. State Street Corp now owns 1,327,586 shares of the company’s stock valued at $30,256,000 after buying an additional 88,517 shares during the period. Wesbanco Bank Inc. increased its stake in shares of Phreesia by 76.9% during the fourth quarter. Wesbanco Bank Inc. now owns 46,000 shares of the company’s stock valued at $1,157,000 after buying an additional 20,000 shares during the period. Finally, Barclays PLC increased its stake in shares of Phreesia by 83.6% during the third quarter. Barclays PLC now owns 94,929 shares of the company’s stock valued at $2,163,000 after buying an additional 43,225 shares during the period. 92.10% of the stock is currently owned by institutional investors.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.